Standout Papers

NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors... 2010 2026 2015 2020 841
  1. NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors (2010)
    George D. Demetri, Margaret von Mehren et al. Journal of the National Comprehensive Cancer Network
  2. Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial (2019)
    Breelyn A. Wilky, Matteo Trucco et al. The Lancet Oncology

Immediate Impact

2 by Nobel laureates 23 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
2023 Standout
The neuroscience of cancer
2023 StandoutNature
1 intermediate paper

Works of Jonathan C. Trent being referenced

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
2020
Midkine Enhances Soft-Tissue Sarcoma Growth: A Possible Novel Therapeutic Target
2008

Author Peers

Author Last Decade Papers Cites
Jonathan C. Trent 4936 3355 2384 276 7.9k
Martin E. Blackstein 3860 2447 1944 99 6.2k
Maria Dêbiec‐Rychter 7297 4051 2629 307 11.9k
Jonathan A. Fletcher 5429 2458 1714 129 9.3k
Axel Le Cesne 7244 2005 4194 267 9.8k
A. van Oosterom 3665 2500 1754 85 6.0k
Agnieszka Woźniak 3294 1916 1523 181 5.1k
Scott M. Schuetze 6220 1267 3261 166 8.5k
William D. Tap 5082 930 3740 283 8.4k
Elena Tamborini 3275 1078 1739 142 5.5k
Kristen N. Ganjoo 3172 1084 1907 170 5.1k

All Works

Loading papers...

Rankless by CCL
2026